Latest Breaking News On - Justin claeys - Page 2 : comparemela.com

FDA APPROVES IMDELLTRA™ (TARLATAMAB-DLLE), THE FIRST AND ONLY T-CELL ENGAGER THERAPY FOR THE TREATMENT OF EXTENSIVE-STAGE SMALL CELL LUNG CANCER

/PRNewswire/ Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved IMDELLTRA™ (tarlatamab-dlle) for the.

Puerto ricoUnited statesJustin claeysJay bradnerDavidp carboneLaurie fenton ambroseMurdo gordonWorld most innovative companiesWorld health organizationAmerican cancer societyOhio state university medical centerBeigene ltdAmgen safety net foundationExchange commissionKyowa kirin co ltdTeneobio inc

AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024

AMGEN TO HOST CONFERENCE CALL FOLLOWING ATS 2024
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesJay bradnerJustin claeysWorld most innovative companiesFast companyInternational conference onAmerican thoracic societyInternational conferenceInvestor relations eventsMost innovativeBest largeDow jones industrialNasdaq stock market

AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024

/PRNewswire/ Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International.

United statesSan diegoPuerto ricoKate meyerJessica akopyanJustin claeysLymphopoietin isoformsJay bradnerWorld most innovative companiesEmergency department visit in patientsTeneobio incChemocentryx incInternational conferenceDrug administrationExchange commissionKyowa kirin co ltd

AMGEN TO SUBMIT TEPROTUMUMAB MARKETING AUTHORIZATION APPLICATION TO THE EUROPEAN MEDICINES AGENCY

/PRNewswire/ Amgen (NASDAQ:AMGN) today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency.

Puerto ricoSaudi arabiaUnited statesUnited kingdomGreat britainKingdom of saudi arabiaJay bradnerMadison howardMario salviJustin claeysJessica akopyanEuropean medicines agencyTherapeutic goods administrationMinistry of healthGraves orbitopathy center aldoFast company

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024

AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomPuerto ricoSan diegoFrance generalJessica akopyanJustin claeysKate meyerLoretta fiorilloCallis duffinPonda motsepe ditshegoMelinda gooderhamJolla institute for immunologyChemocentryx incTeneobio incAmerican academy of dermatology